Therapeutics News

ORLANDO, Fla. – As patients learn more about alternative therapies, one glaucoma specialist still recommends medication first, then elevating low systemic blood pressure – and then supplements.

The progression rate of normal tension glaucoma with myopia may be slow even without the uses of glaucoma medications, according to findings published in the American Journal of Ophthalmology.

Acute angle-closure glaucoma may be associated with the use of gabapentin prior to glaucoma diagnosis, according to a study conducted by the University of British Columbia.

Exonate announced a collaboration with Janssen Pharmaceuticals to develop new eye drops to treat retinal vascular diseases.

No significant difference was seen in efficacy and safety of prostaglandin analogues when comparing original and generics, according to a systematic review published in Ophthalmology Glaucoma.

The ocular surface was found to change in patients treated with prostaglandin analogues, according to a literature review published in the Journal of Ophthalmology.

ORLANDO, Fla. – Fixed combination therapies, new single agents with targeted mechanisms of action, laser surgery and future sustained release technologies may reduce the number of drops glaucoma patients need, Constance O. Okeke, MD, MSCE, said here at the Optometric Glaucoma Society meeting, held prior to the American Academy of Optometry meeting.

NEPTUNE, N.J. – Patients should not needlessly suffer, but optometrists have tools to help them first determine whether a patient is “doctor shopping,” said Tracy Offerdahl, PharmD, RPh, FAAO, here at a New Jersey Academy of Optometry continuing education event.

ORLANDO, Fla. – Kala Pharmaceuticals’ KPI-121 0.25% significantly and rapidly reduced conjunctival hyperemia in three clinical trials, Walt Whitley, OD, said here at the American Academy of Optometry meeting.

Statin therapy was shown to be associated with a decreased risk of diabetic retinopathy in patients with type 2 diabetes and dyslipidemia, according to a study published in JAMA Ophthalmology.